Add Wisconsin to the ever expanding list of states impacted by the measles outbreak. The state’s public health officials indicate that two patients are now isolated and being tested for the disease.

Last week, there were 14 states with 102 infected citizens and public health officials were warning that the outbreak of this formerly eradicated disease was going to spread.  It looks like that prediction is true.

I suspect other states will be joining Wisconsin shortly. Meanwhile, the crisis continues apace in California, as news comes of an infected San Francisco man riding the very public BART system to his job at at LinkedIn and then heading out to a local bistro.

There is some good news to be found amid the notices of fever and rashes, however. Disneyland, the epicenter for many of these cases, isn’t seeing attendance plummet.

The recent measles outbreak hasn’t kept people from visiting Mickey Mouse at Disneyland, says Disney chairman and CEO Bob Iger.

Speaking with Bloomberg news, Iger said his company has “not discerned any real impact from [the measles outbreak] to date” and with an uptick in advanced park visit bookings, “we conclude that there’s really no impact from this.”

…Despite these figures, visits to all domestic Disney park locations were up by 7 percent in the year-end quarter, with both Orlando and Anaheim experiencing all-time high attendance records, according to CFO Jay Rasulo.

Everyone probably had the same idea I did: A great time to go if you are vaccinated! Mickey must breathing a sigh of relief.

For those of you who dabble in stocks, now might be the time to consider expanding the portfolio to include firms that make vaccines. Between flu shots, whooping cough boosters, and the aggressive measles vaccination campaign, the business is growing faster than bacteria in a petrie dish. For example, one of San Diego’s local firms has just seen a huge spike in sales.

Quidel said after the close of the market on Wednesday that its fourth quarter revenues rose 27 percent year over year on strong infectious disease product sales.

For the three months ended Dec. 31, 2014, Quidel reported revenues of $63.6 million compared to $50.2 million in Q4 2013, and ahead of the consensus analysts’ estimate of $61.1 million.

Infectious disease product revenues grew 29 percent led by increased sales of influenza, Group A Strep, and respiratory syncytial virus products, Quidel said. Meantime, women’s health revenues grew 7 percent and gastrointestinal revenues grew 2 percent.

In a conference call recapping the company’s earnings, Quidel President and CEO Douglas Bryant that growth in the quarter came from the firm’s influenza and Strep A products across all platforms; Sofia RSV immunoassay; AmpliVue and Lyra molecular products; and grant revenue.

Another firm, Novavax Inc, has begun early-stage human trials of an Ebola vaccine; the company has the means to manufacture millions of doses of the vaccine every month andplans to develop it further.

One could argue that the country’s new infectious disease awareness arose in the wake of Texas’ Ebola virus infections. Now, lawmakers want to make sure the state is ready if something like that happens again.

Senate Health and Human Services Committee Chairman Charles Schwertner was one of several who pitched Senate Bill 538 Wednesday.

It would allow the governor to declare a state of infectious disease emergency and grant health officials more authority to detain those who may be affected. It would also create a stockpile of protective equipment that could be accessed if an outbreak occurred.

…The bill would also keep the infectious disease preparedness task force established by then-Gov. Rick Perry last year as an advisory board to the current leadership.

More states will likely be developing their own version of such legislation in the near future.  Their requirements should make the firms supplying the equipment and injections even more profitable.

Gone are the days when lifestyle diseases could be the sole focus of our public health officials, businesses, and politicians.  Free market rules apply — we need to create the supply for the new infection control demands in today’s world.

[Featured Image: ABC News Video]